Lantern Pharma: Funding, Investors & Team (Sep 2026)
Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also rescues and revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent therapy combinations. Our approach, which leverages our RADR™ platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.
Lantern Pharma has raised $4.4M across 1 funding round on record, the most recent an undisclosed round of $4.4M announced in May 2026.
That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Lantern Pharma Company Profile and Key Stats
Latest funding round on record: May 2026.
Lantern Pharma Funding Rounds
Lantern Pharma Founders and Leadership Team
Contact details for the Lantern Pharma team: 1 has a LinkedIn profile.
Start 14-day free trial →Lantern Pharma Funding Compared to Other Artificial Intelligence Startups
Lantern Pharma's latest round of $4.4M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lantern Pharma in Artificial Intelligence and Dallas
Companies Similar to Lantern Pharma
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…
Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…
Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…
Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…
Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…
Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…
Lantern Pharma Funding FAQs
What does Lantern Pharma do?
Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also rescues and revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent therapy combinations. Our approach, which leverages our RADR™ platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.
How much funding has Lantern Pharma raised?
Lantern Pharma has raised $4.4M across 1 round on record. The most recent is an undisclosed round of $4.4M announced in May 2026.
When did Lantern Pharma last raise funding?
Lantern Pharma's most recent funding round on record is an undisclosed round of $4.4M, announced in May 2026.
Who founded Lantern Pharma?
FundedIQ lists Panna Sharma (Founder) at Lantern Pharma.
Where is Lantern Pharma headquartered?
Lantern Pharma is based in Dallas, Texas, United States.
How many employees does Lantern Pharma have?
Lantern Pharma is in the 11-50 employee band.
How does Lantern Pharma's funding compare to other Artificial Intelligence startups?
Lantern Pharma's latest round of $4.4M is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Lantern Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lantern Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.